Ashwagandha

KSM-66 full-spectrum Ashwagandha extract

Products
21
NIH LiverTox — hepatotoxicity
Category B · Highly likely cause
About LiverTox →

LiverTox Category B. 2019-2024: rising case reports of idiosyncratic hepatitis. Iceland DHPA 2024 advisory; EU scrutiny ongoing. Heightened risk with existing liver disease or concurrent hepatotoxic drugs.

LiverTox record (NIH NCBI Bookshelf) →
Label dose distribution · 21 labeled products
Min
300 mg
Typical
425 mg
Max
675 mg
Other forms of Ashwagandha

25 sibling forms

Distinct chemical forms sharing the same parent nutrient. Different UNIIs, different bioavailability, different effects — never collapsed.

Top brands carrying KSM-66 full-spectrum Ashwagandha extract

15 brands rolled up

Products containing KSM-66 full-spectrum Ashwagandha extract

21 in catalog